CAJ | 학술논문

据WHO统计数据显示乳腺癌已成为全球妇女首发恶性肿瘤，2000年全球女性乳腺癌新发病例超过100万，在全球范围内，中国的乳腺癌发病率相对较低，但近年已有明显上升的趋势。尽管乳癌的发病率持续上升，但病死率已开始下降，主要得益于更多患者被早期发现和及时治疗，以及更多有效治疗手段的临床应用。但仍有部分患者因发现病变时已为晚期或治疗后复发转移，需接受进一步全身治疗，包括化疗及内分泌治疗，与化疗相比，乳腺癌内分泌治疗的特点是疗效肯定，不良反应轻，接受治疗患者生活质量好，不需要采用止吐、升白细胞等药物，治疗费用相对低，有利于治疗获益患者的长期用药，在辅助治疗中也有更明显的优势。
거WHO통계수거현시유선암이성위전구부녀수발악성종류，2000년전구녀성유선암신발병례초과100만，재전구범위내，중국적유선암발병솔상대교저，단근년이유명현상승적추세。진관유암적발병솔지속상승，단병사솔이개시하강，주요득익우경다환자피조기발현화급시치료，이급경다유효치료수단적림상응용。단잉유부분환자인발현병변시이위만기혹치료후복발전이，수접수진일보전신치료，포괄화료급내분비치료，여화료상비，유선암내분비치료적특점시료효긍정，불량반응경，접수치료환자생활질량호，불수요채용지토、승백세포등약물，치료비용상대저，유리우치료획익환자적장기용약，재보조치료중야유경명현적우세。
According to the WHO statistics show that breast cancer has become the ifrst global women malignant tumor, breast cancer in womenworldwide in 2000, more than 1000000 new cases, globally, Chinesebreast cancer incidence rate is relatively low, but in recent years have been signiifcantly rising trend. Although breast cancer incidence rate continues to rise, but the mortality rate has begun to decline, mainly due to more patients by early discovery and timely treatment, and the clinical application of more effective treatment method. But there are still somepatients because of disease recurrence and metastasis has been foundfor late or after treatment, requiring further systemic treatment, including chemotherapy and endocrine therapy, compared with chemotherapy,characteristics of endocrine therapy for breast cancer is curative effect,less adverse reactions, treated patients life quality, without the use ofantiemetic, white blood cells and so drugs, treatment costs relatively low, long-term medication for treatment beneift patients, in the adjuvant therapy also has more obvious advantage.